TransMedics Group Inc
Company Profile
Business description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Contact
200 Minuteman Road
AndoverMA01810
USAT: +1 978 552-0900
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
728
Stocks News & Analysis
stocks
Is this still an ASX share to own forever?
stocks
After earnings, is Nvidia stock a buy, a sell, or fairly valued?
stocks
Short-term pain for long-term gain for undervalued ASX share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,091.40 | 51.20 | 0.57% |
CAC 40 | 7,698.92 | 20.79 | -0.27% |
DAX 40 | 23,770.33 | 175.53 | 0.74% |
Dow JONES (US) | 45,526.84 | 255.61 | 0.56% |
FTSE 100 | 9,216.87 | 38.88 | 0.42% |
HKSE | 25,058.51 | 284.92 | -1.12% |
NASDAQ | 21,602.92 | 105.19 | 0.49% |
Nikkei 225 | 42,580.27 | 641.38 | 1.53% |
NZX 50 Index | 13,133.20 | 58.39 | 0.45% |
S&P 500 | 6,479.95 | 31.69 | 0.49% |
S&P/ASX 200 | 8,826.50 | 59.20 | 0.68% |
SSE Composite Index | 3,765.88 | 47.68 | -1.25% |